DePuy Synthes Up 1.2% in 3Q19 on Trauma Growth

DePuy Synthes reported 3Q19 orthopedic revenue of USD $2,137MM, +1.2% vs. 3Q18.

Price pressure modestly improved compared to 2Q19, but still negative across all segments with spine, hips and trauma declining 2% and knees declining 1%
Continued strength for ACTIS hip stem and KINCISE automated surgical system, as well as leadership...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

ME

Mike Evers Mike Evers is an analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0